Control Bionics

Milford, United States Founded: 2006 • Age: 20 yrs
Provider of assistive technology devices for speech-impaired people
Request Access

About Control Bionics

Control Bionics is a company based in Milford (United States) founded in 2006 by Peter Ford.. Control Bionics offers products and services including NeuroNode, Trilogy, Cosmos Connect, NeuroStrip, and NeuroNode Accessories. Control Bionics operates in a competitive market with competitors including Tobii Dynavox, Smartbox, AbleNet, Brain Dynamics and Laronix, among others.

  • Headquarter Milford, United States
  • Founders Peter Ford
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Control Bionics Limited
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $4.06 M (USD)
    14.84
    as on Jun 30, 2025
  • Net Profit
    $-4.04 M (USD)
    -3.3
    as on Jun 30, 2025
  • EBITDA
    $-3.86 M (USD)
    3.04
    as on Jun 30, 2025
  • Latest Funding Round
    $3.25 M (USD), Post-IPO

    Dec 01, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Control Bionics

Control Bionics is a publicly listed company on the ASX with ticker symbol CBL in Australia, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: CBL . Sector: Technology services · Australia

Products & Services of Control Bionics

Control Bionics offers a comprehensive portfolio of products and services, including NeuroNode, Trilogy, Cosmos Connect, NeuroStrip, and NeuroNode Accessories. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables communication for individuals with paralysis and speech loss.

Offers faster communication with reduced fatigue for users.

Allows more control with minimal effort for physical needs.

Supports enhanced interaction for assistive technology users.

Provides additional components for improved device functionality.

People of Control Bionics
Headcount 10-50
Employee Profiles 8
Board Members and Advisors 3
Employee Profiles
People
James Schorey
Chief Technology Officer
People
Christie Rowzee
Regional Sales Manager
People
David Combs
Production and Support Specialist
People
Todd Tyler
VP, North America

Unlock access to complete

Board Members and Advisors
people
Lindsay Phillips
Board Member
people
Damian Lismore
Board Member
people
Brett Crowley
Company Secretary

Unlock access to complete

Funding Insights of Control Bionics

  • Total Funding
  • Total Rounds 3
  • Last Round Post-IPO — $3.2M
  • First Round

    (13 Apr 2022)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2025 Amount Post-IPO - Control Bionics Valuation

investors

Jul, 2024 Amount Post-IPO - Control Bionics Valuation

investors

Apr, 2022 Amount Post-IPO - Control Bionics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Control Bionics

Control Bionics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NorthStar Impact and Lindsay Phillips. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity firm focused on housing, education, health, land management, recycling, and renewable energy
Founded Year Domain Location
Offers customizable footwear with interchangeable snaps and straps for consumers.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Control Bionics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Control Bionics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Control Bionics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Control Bionics

Control Bionics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Smartbox, AbleNet, Brain Dynamics and Laronix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
domain founded_year HQ Location
Gift experiences are provided via an online portal by Smartbox.
domain founded_year HQ Location
Offers assistive devices for speech, switches, and computer access support.
domain founded_year HQ Location
Brain-computer interface solutions for paralyzed patients' communication are provided.
domain founded_year HQ Location
Smart wearable voice prostheses are provided for laryngectomees.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Control Bionics

Frequently Asked Questions about Control Bionics

When was Control Bionics founded?

Control Bionics was founded in 2006 and raised its 1st funding round 16 years after it was founded.

Where is Control Bionics located?

Control Bionics is headquartered in Milford, United States.

Who is the current CEO of Control Bionics?

Peter Ford is the current CEO of Control Bionics. They have also founded this company.

What is the annual revenue of Control Bionics?

Annual revenue of Control Bionics is $4.06M as on Jun 30, 2025.

What does Control Bionics do?

Provider of assistive technology devices for speech-impaired people. The GridPad NeuroNode trilogy provides a wearable EMG control device for people with paralysis and loss of speech. Control Bionics CCS is a system including built-in communication software and the EMR access device and related accessories.

Who are the top competitors of Control Bionics?

Control Bionics's top competitors include Smartbox, Tobii Dynavox and Brain Dynamics.

What products or services does Control Bionics offer?

Control Bionics offers NeuroNode, Trilogy, Cosmos Connect, NeuroStrip, and NeuroNode Accessories.

Is Control Bionics publicly traded?

Yes, Control Bionics is publicly traded on ASX under the ticker symbol CBL.

Who are Control Bionics's investors?

Control Bionics has 2 investors. Key investors include NorthStar Impact, and Lindsay Phillips.

What is Control Bionics's ticker symbol?

The ticker symbol of Control Bionics is CBL on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available